Conflict, what conflict?
作者信息
Wilkes M S
出版信息
West J Med. 2000 Jan;172(1):6-8. doi: 10.1136/ewjm.172.1.6.
Abstract
摘要
相似文献
1
Conflict, what conflict?冲突，什么冲突？
West J Med. 2000 Jan;172(1):6-8. doi: 10.1136/ewjm.172.1.6.
2
Is academic medicine for sale?学术医学可以买卖吗？
N Engl J Med. 2000 May 18;342(20):1516-8. doi: 10.1056/NEJM200005183422009.
3
Conflicts about Conflict of Interest.关于利益冲突的冲突
Camb Q Healthc Ethics. 2016 Jul;25(3):526-35. doi: 10.1017/S0963180116000177.
4
Inner turmoil: an important consideration in conflicts of interest.内心冲突：利益冲突中的一个重要考量因素。
J Clin Ethics. 1995 Winter;6(4):367-71.
5
Lunch with Lilly: who pays?与莉莉共进午餐：谁来买单？
Am J Bioeth. 2003 Summer;3(3):62-3. doi: 10.1162/15265160360706651.
6
Physician-drug company conflict of interest.医生与制药公司的利益冲突。
J Clin Oncol. 1996 Jan;14(1):316-20. doi: 10.1200/JCO.1996.14.1.316.
7
Biased articles.有偏见的文章。
Med Health R I. 2009 Mar;92(3):70.
8
Bioethics for clinicians: 17. Conflict of interest in research, education and patient care.临床医生的生物伦理学：17. 研究、教育与患者护理中的利益冲突。
CMAJ. 1998 Oct 20;159(8):960-5.
9
Winds of change: growing demands for transparency in the relationship between doctors and the pharmaceutical industry.变革之风：对医生与制药行业关系透明度的需求日益增长。
Med J Aust. 2010 Mar 1;192(5):293-4. doi: 10.5694/j.1326-5377.2010.tb03517.x.
10
How do we guarantee trainee professional purity?
J Vasc Surg. 2009 Mar;49(3):790-1. doi: 10.1016/j.jvs.2008.12.069.
引用本文的文献
1
Should the drug industry work with key opinion leaders? No.制药行业应该与关键意见领袖合作吗？不应该。
BMJ. 2008 Jun 21;336(7658):1405. doi: 10.1136/bmj.39541.731493.59.
2
Financial conflicts of interest in psychiatry.精神医学中的财务利益冲突。
World Psychiatry. 2007 Feb;6(1):19-24.
3
Conflicts between commercial and scientific interests in pharmaceutical advertising for medical journals.医学期刊药品广告中商业利益与科学利益之间的冲突。
Int J Health Serv. 2003;33(4):751-68. doi: 10.2190/K0JG-EXG1-FB12-0ANF.
本文引用的文献
1
Clozapine versus typical neuroleptic medication for schizophrenia.氯氮平与传统抗精神病药物治疗精神分裂症的比较。
Cochrane Database Syst Rev. 2000(2):CD000059. doi: 10.1002/14651858.CD000059.
2
Perspectives. The AMA after Sunbeam: tremor in the house of medicine.
Med Health. 1998 Jan 26;52(4):suppl 1-4.
3
Beyond conflict of interest. Transparency is the key.超越利益冲突。透明度是关键。
BMJ. 1998 Aug 1;317(7154):291-2. doi: 10.1136/bmj.317.7154.291.
4
Thyroid storm.甲状腺危象
JAMA. 1997 Apr 16;277(15):1238-43.
5
The quality of drug studies published in symposium proceedings.专题研讨会论文集中发表的药物研究质量。
Ann Intern Med. 1996 Mar 1;124(5):485-9. doi: 10.7326/0003-4819-124-5-199603010-00004.
6
"Self referral": a potential conflict of interest.“自我推荐”：一种潜在的利益冲突。
BMJ. 1993 Apr 24;306(6885):1083-4. doi: 10.1136/bmj.306.6885.1083.
7
A study of manufacturer-supported trials of nonsteroidal anti-inflammatory drugs in the treatment of arthritis.一项关于制造商支持的非甾体抗炎药治疗关节炎试验的研究。
Arch Intern Med. 1994 Jan 24;154(2):157-63.
8
Source of funding and outcome of clinical trials.临床试验的资金来源与结果
J Gen Intern Med. 1986 May-Jun;1(3):155-8. doi: 10.1007/BF02602327.
9
Frequency and costs of diagnostic imaging in office practice--a comparison of self-referring and radiologist-referring physicians.门诊实践中诊断性成像的频率和成本——自我转诊医生与放射科转诊医生的比较
N Engl J Med. 1990 Dec 6;323(23):1604-8. doi: 10.1056/NEJM199012063232306.
Zotero 插件